Evidence map›Paper›PMID 23867794›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2014

Infantile exposure to lead and late-age cognitive decline: relevance to AD.

Syed Waseem Bihaqi, Azadeh Bahmani, Gehad M Subaiea, Nasser H Zawia

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 93 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Metals in Alzheimer's Disease.Biomedicines · 2023
    Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Half of US population exposed to adverse lead levels in early childhood.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Evaluation of chronic lead effects in the blood brain barrier system by DCE-CT.Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) · 2020
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Syed Waseem BihaqiDepartment of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, RI, USA.
Azadeh BahmaniInterdisciplinary Neuroscience Program (INP), University of Rhode Island, Kingston, RI, USA.
Gehad M SubaieaDepartment of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, RI, USA.
Nasser H ZawiaDepartment of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, RI, USA; Interdisciplinary Neuroscience Program (INP), University of Rhode Island, Kingston, RI, USA. Electronic address: nzawia@uri.edu.
University of Rhode Island · US

Funding

UNDERGRADUATE RESEARCH AND SEMINARSP20RR016457 · NCRR · UNIVERSITY OF RHODE ISLAND · PI SHAKARIAN, ALISON M · 2001 to 2011
$35.5M
Occupational exposure and the developmental-basis of ADR01ES015867 · NIEHS · UNIVERSITY OF RHODE ISLAND · PI ZAWIA, NASSER HUSSEIN · 2009 to 2012
$1.2M
Intramural NIH HHSNCRR NIH HHS P20 RR016457NCRR NIH HHS P20RR016457)NIEHS NIH HHS 5R01ES015867-03NIEHS NIH HHS R01 ES015867
6 · The paper itself

Abstract

backgroundEarly-life lead (Pb) exposure induces overexpression of the amyloid beta precursor protein and its amyloid beta product in older rats and primates. We exposed rodents to Pb during different life span periods and examined cognitive function in old age and its impact on biomarkers associated with Alzheimer's disease (AD).

methodsMorris, Y, and the elevated plus mazes were used. Western blot, quantitative polymerase chain reaction (qPCR), and enzyme-linked immunosorbent assay were used to study the levels of AD biomarkers.

resultsCognitive impairment was observed in mice exposed as infants but not as adults. Overexpression of AD-related genes (amyloid beta precursor protein and β-site amyloid precursor protein cleaving enzyme 1) and their products, as well as their transcriptional regulator-specificity protein 1 (Sp1)-occurred only in older mice with developmental exposure to Pb.

conclusionsA window of vulnerability to Pb neurotoxicity exists in the developing brain that can influence AD pathogenesis and cognitive decline in old age.

Indexed as

AgingAmyloid beta-PeptidesAmyloid beta-Protein PrecursorAmyloid Precursor Protein SecretasesAnimalsAnimals, NewbornAntimicrobial Cationic PeptidesAspartic Acid EndopeptidasesCognition DisordersDisease Models, AnimalEnzyme-Linked Immunosorbent AssayFemaleGene Expression Regulation, DevelopmentalHumansLeadMaleAmyloid beta-Peptidesamyloid beta-protein (1-40)amyloid beta-protein (1-42)Amyloid beta-Protein PrecursorAmyloid Precursor Protein SecretasesAntimicrobial Cationic Peptidesarginyl-lysyl-lysyl-arginyl-leucyl-lysyl-leucyl-leucyl-lysyl-arginyl-leucyl-leucinamideAspartic Acid EndopeptidasesBace1 protein, mouseLeadPeptide FragmentsRNA, MessengerAgingAlzheimer's diseaseCognitionDevelopmentLeadLife span

Identifiers

PMID23867794
PMCPMC3864613
OpenAlexW2103175232

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.